Catalyst Wire Dossier Catalyst Wire Dossier

Xoft Axxent Electronic Brachytherapy System

· Xoft, a division of iCAD, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Xoft Axxent Electronic Brachytherapy System, covering 2016-05-17 to 2025-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy [Phase 1]

See pricing